Clinical Trial

Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to determine if the addition of Rocklatan post-Hydrus will provide additional intraocular pressure lowering.
Trial Details
NCT Number NCT07048886
Lead Sponsor Center for Sight Las Vegas
Conditions Primary Open Angle Glaucoma
Enrollment 68 participants
Start Date 2025-07-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-03